NICE approves combination therapy for hepatitis C

Combination drugs for hepatitis C have been recommended by the National Institute for Clinical Excellence. NICE said that patients suffering from moderate or severe hepatitis C should be given a combination of the drugs interferon alpha and ribavirin. Until June 1999, interferon alpha was the only licensed treatment for chronic ...

You need to be an HSJ subscriber to read more


Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to
  • The HSJ app

Enquire about multi-user access